Andrew Leader Cramer
Neurology · Peabody, MANPI 1942278171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,272 and has fallen 97.3% since, to $34 in 2023.
Across 84 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$326
- AbbVie$143
- Supernus Pharmaceuticals, Inc.$103
- Sanofi$102
- GE HealthCare$91
- Amgen$77
- plus $767 from 20 others
What the payments were for
- Speaking & faculty fees$553%
- Food & beverage$1,55497%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 21 | $326 |
| AbbVie(2 entities) | 7 | $143 |
| Supernus Pharmaceuticals, Inc. | 2 | $103 |
| Sanofi | 5 | $102 |
| GE HealthCare | 4 | $91 |
| Amgen | 3 | $77 |
| Acorda Therapeutics, Inc | 4 | $70 |
| Sunovion Pharmaceuticals Inc. | 4 | $69 |
| MDD US Operations, LLC | 4 | $65 |
| EMD Serono, Inc. | 2 | $63 |
| Lilly USA, LLC | 3 | $53 |
| Grifols USA, LLC | 2 | $47 |
| Amneal Pharmaceuticals LLC | 3 | $42 |
| Kyowa Kirin, Inc. | 2 | $40 |
| UCB, Inc. | 2 | $38 |
| Tanabe Pharma America, Inc. | 2 | $37 |
| Acadia Pharmaceuticals Inc | 2 | $36 |
| Vertical Pharmaceuticals, LLC | 2 | $35 |
| Genentech USA, Inc. | 2 | $34 |
| Avanir Pharmaceuticals, Inc. | 2 | $34 |
| Greenwich Biosciences, Inc. | 1 | $25 |
| Strongbridge US Inc. | 1 | $19 |
| Biogen | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$1,609 in reported general payments places this provider in the 60th percentile of 761 neurology providers in Massachusetts.
Other neurology in Peabody
- Christopher WrightBoston$2.5M
- Shivang JoshiWestborough$1.2M
- Egilius SpieringsWellesley Hills$680K
- Thomas ScammellBoston$617K
- Salvatore NapoliFoxboro$613K
- Alfred SandrockBoston$490K
- Joshua KatzWellesley$462K
- Guy BuckleBrookline$450K
- Pushpa NarayanaswamiBoston$420K
- Kenneth GorsonWellesley$414K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.